General Genomics Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2024 | $3 M | No. 2 | $2 to $10 million | equity, debt | SEC | |
| Aug 2021 | $1 M | No. 1 | Under $2 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
General Genomics Inc. reported revenue of $440,579 for its fiscal year to 31 December 2023 (filed Apr 2024), up from $8,269 the year before.
SEC Form C-AR · Apr 2024
Net loss for the same year: $606,779.
SEC Form C-AR · Apr 2024
The industry group it chose in its notices: Other.
SEC Form D · Jan 2026
In its own words
How the company describes itself to search engines on its website, word for word.
“Discover how General Genomics cutting-edge bioinformatics and AI solutions can transform your operations. Our services are tailored to your industry needs, showcasing how our innovative tools streamline workflows, unlock new insights, and empower data-driven decisions.”
Source: The company's website · as of Nov 15, 2026
Products and services#
No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.
Investors#
No investor of General Genomics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 21 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Aronjol Rosenthal | Executive officer | Jan 2026 |
| Aronjol Rosenthal | Director | Jan 2026 |
| Caleb Stuart | Director | Jan 2026 |